Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tinea capitis is a common scalp infection causing hair loss, mostly in young children.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Regulatory T cells are essential for normal and improved wound healing in mice.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Taurine helps protect and promote hair growth.

Tick bites can cause localized hair loss.

Oxytocin receptor changes in hair cells may help identify autism, especially in males.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

The program increased awareness of traction alopecia but didn't significantly change hairstyling habits.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Tretinoin cream successfully treated a woman's skin condition called Fox-Fordyce disease.

Talquetamab may cause hair loss and skin issues.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Rubbing or pressing on the face can cause small bumps, and changing posture along with certain creams can improve them.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.